Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hemostatic Disorders × Dipyrone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hemostatic Disorders 1 Agnosia 1

Interventions

dacetuzumab 2 Bortezomib 2 epratuzumab 1 Vorinostat 1 Lenalidomide 1 Dipyrone 1 Dexamethasone 1 Calcium Dobesilate 1 ARQ531 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07384013 2026-02-03

Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs

Rambam Health Care Campus

Phase NA Recruiting

Agnosia, Hemostatic Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡